Suppr超能文献

主要茶多酚(-)-表没食子儿茶素没食子酸酯和视黄酸对宫颈腺癌的抗增殖作用。

Antiproliferative effects of the major tea polyphenol, (-)-epigallocatechin gallate and retinoic acid in cervical adenocarcinoma.

作者信息

Yokoyama Msatoshi, Noguchi Mitsuyo, Nakao Yoshifumi, Ysunaga Makio, Yamasaki Fumio, Iwasaka Tsuyoshi

机构信息

Department of Obstetrics and Gynecology, Faculty of Medicine, Saga University, 5-1-1, Nabeshima, Saga, 849-8501, Japan.

出版信息

Gynecol Oncol. 2008 Feb;108(2):326-31. doi: 10.1016/j.ygyno.2007.10.013. Epub 2007 Nov 26.

Abstract

OBJECTIVE

To investigate the combined effect of the major tea polyphenol, (-)-epigallocatechin gallate (EGCG) and retinoic acid (RA) on cervical adenocarcinoma.

METHODS

Cell growth rate was examined after treatment for 4, 7 and 10 days with 0-100 microM EGCG and/or 1 microM RA in two cervical adenocarcinoma cell lines, HeLa and TMCC-1. The effect of EGCG treatment was examined for the induction of apoptosis by DNA ladder assay and caspase-3-related protease activity in cell lysate. Telomerase activity was detected by stretch PCR telomere extension assay. hTERT expression levels were quantified by a real-time PCR system.

RESULTS

Combining EGCG and RA increased the antiproliferative effect in adenocarcinoma cell lines, whereas EGCG or RA treatment alone caused a less sensitive response in these cells. Neither EGCG nor RA treatment alone affected apoptosis and telomerase activity. The combination treatment of EGCG and RA induced apoptosis and inhibited telomerase activity in adenocarcinoma cell lines. These results were consistent with those of an antiproliferative effect of EGCG and/or RA in cervical adenocarcinoma cells.

CONCLUSION

Our data suggest that EGCG and RA combined to prevent the carcinogenesis of cervical adenocarcinoma, induce apoptosis and inhibit telomerase activity. The treatments of combining EGCG and RA may be effective in preventing or treating cervical adenocarcinoma.

摘要

目的

研究主要茶多酚(-)-表没食子儿茶素没食子酸酯(EGCG)与视黄酸(RA)联合对宫颈腺癌的作用。

方法

用0-100微摩尔EGCG和/或1微摩尔RA处理两种宫颈腺癌细胞系HeLa和TMCC-1,分别于处理4、7和10天后检测细胞生长速率。通过DNA梯状条带分析和细胞裂解液中与半胱天冬酶-3相关的蛋白酶活性检测EGCG处理对细胞凋亡诱导的影响。采用伸展PCR端粒延伸分析法检测端粒酶活性。通过实时PCR系统定量检测人端粒酶逆转录酶(hTERT)表达水平。

结果

EGCG与RA联合使用可增强对腺癌细胞系的抗增殖作用,而单独使用EGCG或RA处理这些细胞时反应较不敏感。单独使用EGCG或RA处理均不影响细胞凋亡和端粒酶活性。EGCG与RA联合处理可诱导腺癌细胞系凋亡并抑制端粒酶活性。这些结果与EGCG和/或RA对宫颈腺癌细胞的抗增殖作用结果一致。

结论

我们的数据表明,EGCG与RA联合可预防宫颈腺癌的发生,诱导凋亡并抑制端粒酶活性。EGCG与RA联合治疗可能对预防或治疗宫颈腺癌有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验